Annual Gross Revenue: increase of 36% in relation to the same period of the previous year.
Annual EBITDA (% R.L.): increase of 6.7 p.p. / ROIC: increase of approx. 11 p.p.
1st. Free Cash Flow (+): R$ 66 MM (2009).
Evolution of the company's share value 🡪 Variations: Project start year: + 155%, project year: +59%.
Adequacy of the organizational structure according to the business model / span of control: 40% reduction in the number of Vice-presidencies and 50% in the number of regional directors.
Adequacy of action channels: creation of the hospital channel and clear definition of the action strategy of the other 3 (Private, Public, Third Parties).
Earnings: Products + Units: approximately R$ 40MM / Purchases: R$ 23 MM / Matrix: R$ 38 MM.